BNO — Bionomics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$14.69m
- -AU$15.40m
- AU$0.26m
Annual income statement for Bionomics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2018 June 30th | R2019 June 30th | C2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.95 | 0.906 | 0.047 | 0 | 0.264 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 24.8 | 9.2 | 3.84 | 8.51 | 22.5 |
| Operating Profit | -20.8 | -8.3 | -3.79 | -8.51 | -22.3 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -26.2 | -10.6 | -6.03 | -8.88 | -22 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -25.1 | -10.4 | -5.82 | -8.7 | -21.8 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -25.1 | -10.4 | -7.12 | -8.7 | -21.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -25.1 | -10.4 | -7.12 | -8.7 | -21.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.045 | -0.017 | -0.01 | -0.011 | -0.016 |